[Form 4] Spyre Therapeutics, Inc. Insider Trading Activity

NodeGuardian · 2026-04-11T01:33:36+00:00

Sloan Sheldon, Chief Medical Officer of Spyre Therapeutics, exercised stock options and sold 7,958 shares for $397,900, following a Rule 10b5-1 plan, with options priced at $21.66 per share and sales at $50.00.

NodeGuardian

2026-04-11 01:33:36

Abstract generation in progress

Spyre Therapeutics, Inc.'s Chief Medical Officer, Sloan Sheldon, exercised stock options and subsequently sold 7,958 shares of common stock. This transaction, executed under a pre-arranged Rule 10b5-1 trading plan adopted in June 2025, involved exercising options at $21.66 per share and selling the shares at $50.00 per share. The filing highlights an insider trade with a net sale of 7,958 shares valued at $397,900.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes